Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KOH 5% solution vs fluorouracil 5% cream for actinic keratosis
IRCT20180909040978N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluorouracil and potassium hydroxide in actinic keratosis (AK) (2 arms), sponsored by Tehran University of Medical Sciences. Started Oct 2018; status: completed.
02
Drugs
fluorouracilpotassium hydroxide
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on IRCT20180909040978N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180909040978N1.